Post-transplant minimal residual disease assessment in Multiple myeloma

Mookerjee, Anjali ; Dahiya, Meetu ; Gupta, Ritu ; Kumar, Rakesh ; Sharma, Atul ; Luthra, Kalpana ; Sharma, Alpana ; Kaur, Gurvinder ; Saxena, Renu ; Pandey, Ravindra Mohan ; Sharma, Om Dutt ; Sahoo, Ranjit ; Kumar, Lalit (2019) Post-transplant minimal residual disease assessment in Multiple myeloma Clinical Lymphoma Myeloma and Leukemia, 19 (10). e180. ISSN 2152-2650

Full text not available from this repository.

Official URL: https://doi.org/10.1016/j.clml.2019.09.301

Related URL: http://dx.doi.org/10.1016/j.clml.2019.09.301

Abstract

MRD status was assessed in MM patients undergoing high-dose Melphalan and autologous stem cell transplantation (ASCT). The primary objective of this study was to determine the MRD negativity rate in this population.

Item Type:Article
Source:Copyright of this article belongs to Elsevier Science.
ID Code:142231
Deposited On:22 Jan 2026 17:41
Last Modified:22 Jan 2026 17:41

Repository Staff Only: item control page